Biomarkers · Chemical
Apolipoprotein A-1
- Primary unit
- mg/dL
- LOINC codes
- 1869-7
- Tests that measure Apolipoprotein A-1
- Labcorp 7, Quest Diagnostics 5
Ranges
Each lab publishes a reference range for the population groups it tests, usually the middle 95% of results. These intervals describe that population, not an optimal or healthy target. How ranges differ
Quest Diagnostics, Apolipoprotein A1 5223
| Risk Category | Male | Female |
|---|---|---|
| Male | ≥115 mg/dL | |
| Female | ≥125 mg/dL | |
| Optimal | ≥115 mg/dL | ≥125 mg/dL |
| High | <115 mg/dL | <125 mg/dL |
Quest Diagnostics, Cardio IQ® Apolipoprotein A-1 91724
| Risk Category | Male | Female |
|---|---|---|
| Male | ≥115 mg/dL | |
| Female | ≥125 mg/dL | |
| Optimal | ≥115 mg/dL | ≥125 mg/dL |
| High | <115 mg/dL | <125 mg/dL |
Tests
Check the catalog code, specimen, method and preparation for every test that measures Apolipoprotein A-1. Select up to five tests to compare them side by side.
Labcorp 7 tests
Single-analyte tests
Apolipoprotein A-1 016873
Serum · Fasting not stated · Turnaround 1 - 2 days
Labcorp catalog pageMethod and collection
- Method
- Immunologic
- Collection
- Separate serum or plasma from cells. Transfer specimen to a plastic transport tube.
- Reference notes
- See table. Male (mg/dL) 0 to 14 d | 62−91 15 d to 11 m | 53−175 1 to 5 y | 80−164 6 to 12 y | 107−175 >12 y | 101−178 Female (mg/dL) 0 to 14 d | 71−97 15 d to 11 m | 53−175 1 to 5 y | 80−164 6 to 80 y | 116−209 >80 y | 114−214
Panels that include this biomarker
Apolipoprotein Assessment 216010
3 analytes · Serum · Fasting not stated · Turnaround 1 - 2 days
Labcorp catalog pageMethod and collection
- Method
- Immunologic
- Collection
- Separate serum or plasma from cells within 45 minutes. Transfer specimen to a plastic transport tube.
- Reference notes
- See tables. Apolipoprotein A-1 Male (mg/dL) 0 to 14 d | 62−91 15 d to 11 m | 53−175 1 to 5 y | 80−164 6 to 12 y | 107−175 >12 y | 101−178 Female (mg/dL) 0 to 14 d | 71−97 15 d to 11 m | 53−175 1 to 5 y | 80−164 6 to 80 y | 116−209 >80 y | 114−214 Apolipoprotein B1 Age | Male (mg/dL) | Female (mg/dL) 0 to 14 d | 9−67 | 9−67 15 d to 11 m | 19−123 | 19−123 1 to 5 y | 41−93 | 41−93 >5 y | 52−135 | 54−133 Apolipoprotein B:A-1 Ratio Male | Female Average risk | 0.7 | 0.6 2x average risk | 0.9 | 0.9 3x average risk | 1.0 | 1.0
Hepatitis B Virus (HBV) FibroSure® 550605
8 analytes · Serum · Fasting not stated · Turnaround 3 - 5 days
Labcorp catalog pageMethod and collection
- Method
- See individual test components.
- Preparation
- Patient should be fasting for at least eight hours.
- Collection
- Separate serum from cells within two hours of collection, and transfer serum to a transfer tube.
Hepatitis C Virus (HCV) FibroSure® 550123
8 analytes · Serum · Fasting not stated · Turnaround 3 - 5 days
Labcorp catalog pageMethod and collection
- Method
- See individual test components.
- Preparation
- Patient should be fasting for at least eight hours.
- Collection
- Separate serum from cells within two hours of collection, and transfer serum to a transfer tube.
- Reference notes
- See tables. METAVIR Group Scoring System Fibrosis Stage (FibroTest) | Range F0−No fibrosis | 0.00−0.21 F0−F1 | >0.21−0.27 F1−Portal fibrosis | >0.27−0.31 F1−F2 | >0.31−0.48 F2−Bridging fibrosis with few septa | >0.48−0.58 F3−Bridging fibrosis with many septa | >0.58−0.72 F3−F4 | >0.72−0.74 F4−Cirrhosis | >0.74−1.00 Activity Stage (ActiTest) | Range A0−No activity | 0.00−0.17 A0−A1 | >0.17−0.29 A1−Minimal activity | >0.29−0.36 A1−A2 | >0.36−0.52 A2−Moderate activity | >0.52−0.60 A2−A3 | >0.60−0.63 A3−Severe activity | >0.63−1.00
ASH FibroSure® 550180
12 analytes · Serum · Fasting not stated · Turnaround 3 - 6 days
Labcorp catalog pageMethod and collection
- Preparation
- Patient should be fasting for at least eight hours.
- Collection
- Separate serum from cells within two hours of collection, and transfer serum to a transfer tube.
NASH FibroSure® Plus 550960
13 analytes · Serum · Fasting not stated · Turnaround 4 - 6 days
Labcorp catalog pageMethod and collection
- Method
- See individual test components.
- Preparation
- Patient should be fasting for at least eight hours.
- Collection
- Separate serum from cells within two hours of collection, and transfer serum to a transfer tube.
Quest Diagnostics 5 tests
Single-analyte tests
Apolipoprotein A1 5223
Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoturbidimetric
Cardio IQ® Apolipoprotein A-1 91724
Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoturbidimetric
Panels that include this biomarker
Apolipoprotein Evaluation 7018
3 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoturbidimetric
- Reference notes
- Apolipoprotein A1 Male | ≥115 mg/dL Female | ≥125 mg/dL Risk Category | Male | Female Optimal | ≥115 mg/dL | ≥125 mg/dL High | <115 mg/dL | <125 mg/dL Cardiovascular event risk category cut points (optimal, high) are based on the AMORIS study, Walldius G et al. J Intern Med. 2004;255:188-205. Apolipoprotein B | <90 mg/dL Risk Category Optimal | <90 mg/dL Moderate | 90-129 mg/dL High | ≥130 mg/dL A desirable treatment target may be <80 mg/dL or lower depending on the risk category of the patient including patients on lipid lowering therapies, patients with ASCVD, diabetes with >1 risk factors, Stage 3 or greater CKD with albuminuria, or heterozygous familial hypercholesterolemia. ApoB relative risk category cut points are based on AACE/ACE and ACC/AHA recommendations (Grundy SM, et al. 2019. doi:10.1016/j.jacc.2018.11.002; Handelsman Y, et al. 2020. doi:10.4158/CS-2020-0490). Apolipoprotein B/A1 Ratio Male | <0.77 Female | <0.63 Risk Category | Male | Female Optimal | <0.77 | <0.63 Moderate | 0.77-0.95 | 0.63-0.78 High | >0.95 | >0.78 Cardiovascular event risk category cut points (optimal, moderate, high) are based on the AMORIS study, Walldius G et al. J Intern Med. 2004;255:188-205.
Cardio IQ® Apolipoprotein Evaluation 91727
3 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoturbidimetric
- Reference notes
- Apolipoprotein A1 Male | ≥115 mg/dL Female | ≥125 mg/dL Risk Category | Male | Female Optimal | ≥115 mg/dL | ≥125 mg/dL High | <115 mg/dL | <125 mg/dL Cardiovascular event risk category cut points (optimal, high) are based on the AMORIS study, Walldius G et al. J Intern Med. 2004;255:188-205. Apolipoprotein B | <90 mg/dL Risk Category Optimal | <90 mg/dL Moderate | 90-129 mg/dL High | ≥130 mg/dL A desirable treatment target may be <80 mg/dL or lower depending on the risk category of the patient including patients on lipid lowering therapies, patients with ASCVD, diabetes with >1 risk factors, Stage 3 or greater CKD with albuminuria, or heterozygous familial hypercholesterolemia. ApoB relative risk category cut points are based on AACE/ACE and ACC/AHA recommendations (Grundy SM, et al. 2019. doi:10.1016/j.jacc.2018.11.002; Handelsman Y, et al. 2020. doi:10.4158/CS-2020-0490). Apolipoprotein B/A1 Ratio Male | <0.77 Female | <0.63 Risk Category | Male | Female Optimal | <0.77 | <0.63 Moderate | 0.77-0.95 | 0.63-0.78 High | >0.95 | >0.78 Cardiovascular event risk category cut points (optimal, moderate, high) are based on the AMORIS study, Walldius G et al. J Intern Med. 2004;255:188-205.
Liver Fibrosis, FibroTest-ActiTest Panel 92688
12 analytes · Serum · Fasting not stated · Turnaround Set up: Mon-Sat; Report available: 2-5 days
Quest Diagnostics catalog pageMethod and collection
- Method
- Nephelometry • Spectrophotometry (SP)
- Preparation
- Overnight fasting is preferred
- Collection
- Serum should be separated from the cells as soon as possible after visible clot formation (usually 15-30 minutes after collection). Avoid freezing and thawing.
- Reference notes
- See Laboratory Report
0 of 5 tests selected
Pick one moreSources
7 tests: codes, specimens, methods, preparation and reference intervals.
Quest Diagnostics test catalog
5 tests: codes, specimens, methods, preparation and reference intervals.
LOINC 1869-7
Regenstrief Institute codes that identify the same result across labs.
Search ClinicalTrials.gov for Apolipoprotein A-1
Registered studies that measure Apolipoprotein A-1, on the U.S. National Library of Medicine registry.
Verify these ranges and sources
We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.
Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.